Skip to content

IMDX IMDX Change in AP

Change in AP at other companies

CareDx logo
CareDxCDNA
-$338K-190%
Natera, Inc. logo
Natera, Inc.NTRA
$21.88M+820%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
-$408K+38.0%
Agilent Technologies logo
Agilent TechnologiesA
$15M+150%
Personalis, Inc. logo
Personalis, Inc.PSNL
-$809K-140%
GeneDx Holdings logo
GeneDx HoldingsWGS
-$13.17M-222%

Other financials

Income statement

See full
Revenue$32.0K-98.5%
Gross profit$15.0K-98.9%
Operating income-$4.4M+35.1%
Net income-$4.3M+35.7%
EPS (diluted)-$0.12+53.8%

Balance sheet

See full
Cash & equivalents$28.2M-9.1%
Total debt$2.9M-13.5%
Total equity-$10.7M-205%
Total assets$40.4M-33.0%

Cash flow

See full
Operating cash flow-$7.6M-30.8%
CapEx$613.0K+99.7%
Free cash flow-$8.3M-34.3%

Valuation

See full
Market cap$185.35M+92.3%
Enterprise value$160.03M+113%
P/S95.1×+72.5×

Profitability

See full
Gross margin51.3%-3.0pp
Operating margin-2,500.7%+4,459pp
Net margin-2,454.6%+4,017pp
FCF margin-1,409.7%-6,023pp

Returns & leverage

See full
Return on equity-532.9%-717pp
Debt / equity2.9×+2.8×
Current ratio2.5×-1.2×

Where this comes from

Reported directly by IMDX in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.

The official record: IMDX’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about IMDX's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is IMDX's change in AP?
IMDX (IMDX) reported change in AP of -$105K in Q1 2026.
How has IMDX's change in AP changed year-over-year?
IMDX's change in AP decreased by 110.2% year-over-year, from $1.03M to -$105K.
What is the long-term trend for IMDX's change in AP?
Over 2 years (2023 to 2025), IMDX's change in AP has grown at a -26.4% compound annual growth rate (CAGR), from -$4.88M to $2.65M.
What does change in AP mean?
Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.